2026 ASCO Direct™ GU

 

Total Health’s 2026 ASCO Direct™ Genitourinary Cancer Conference is an officially licensed ASCO Direct™ meeting. This Post-ASCO Genitourinary Cancers Symposium Review highlights key abstracts from top-rated presentations, providing attendees with direct access to the latest research and strategies in GU oncology education. The accredited meeting will be hosted as an in-person meeting only available exclusively to registered participants.

 

Accreditation Information | 7.5

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
  • Amedco LLC designates this activity for a maximum of 7.5 ANCC contact hours.

  • Amedco LLC designates this live activity for a maximum of 7.5 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Amedco LLC designates this activity for a maximum of 7.5 knowledge-based CPE contact hours.

    JA4008163-9999-26-021-L01-P | JA4008163-9999-26-021-L01-T

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

  • Acknowledgement of Financial Commercial Support

    No financial commercial support was received for this educational activity.

    Acknowledgement of In-Kind Commercial Support

    No in-kind commercial support was received for this educational activity.

    Satisfactory Completion

    Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

    Joint Accreditation Statement

    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163

    Physicians

    Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists & Pharmacy Technicians
    Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours. JA4008163-9999-26-070-L01-P | JA4008163-9999-26-070-L01-T

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
    Credits are generally reported during the first week of each month for those who claimed during the month prior.

    Nurses

    Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours

    American Board of Internal Medicine (ABIM) MOC
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS. Credits are generally reported during the first week of each month for those who claimed during the month prior.

    Objectives - After Attending This Program You Should Be Able To

    1. Review and analyze the latest therapeutic advances for the treatment and management of GU cancers

    2. Apply new data and therapeutic advances into guideline-driven treatment strategies to improve the care of patients with prostate, bladder, kidney, and other genitourinary cancers

    3. Identify subpopulations of patients with GU cancers most likely to benefit from specific treatment plans based on prognostic or predictive markers

    Disclosure of Conflict of Interest

    The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5) All individuals in a position to control the content of CE are listed below.

    Name Commercial Interest: Relationship
    Pedro Barata Merck, Eisai, EMD Serono, Pfizer, Caris Life Sciences, AstraZeneca, Exelixis, Bayer:Consultant UroToday, Targeted Oncology :Scientific/Medical Advisory Board Member


    Atish Choudhury Lantheus, Tolmar, Janssen / Johnson & Johnson, Pfizer, Astellas, Bayer, Daiichi Sankyo, Boundless Bio, Novartis:Consultant Pfizer, Bayer, Sumitomo, Eli Lilly:Research Grant Overall Principal Investigator

    Pauline Funchain Ideaya, Linnaeus:Research Grant Site Principal Investigator Immunocore, Sanofi, Tempus:Consultant

    David Gau NA

    Sophia Kamran NA

    Bradley McGregor Arcus, Aveo, BMS, AZ, Daichi, Gilead, Bayer, Exelixis, Pfizer, Eisai, Genmab:Consultant BMS, Gilead, Exelixis:Research Grant Overall Principal Investigator Exelixis, Aveo, Bayer:Research Grant Site Principal Investigator

    Karie Runcie NA

    Michael Serzan NA

    Neil Shah Merck, Pfizer, BMS, MJH, Aravive, Exelixis:Consultant

    Xiao Wei NA

    Reyna Wilhelm NA

    Justin Kaiser NA

    How to Get Your Certificate

    1. Go to thc.cmecertificateonline.com

    2. Click on the 2026 ASCO Direct GU link.

    3. For ABIM MOC click on the 2026 ASCO Direct GU ABIM MOC link.

    4. Evaluate the meeting.

    5. Print, download, or save your certificate for your records.

    6. If you lose your certificate, or need help, go to help.cmecertificateonline.com

 
 

How to Get Your Certificate

Go to thc.cmecertificateonline.com

Evaluate the meeting.

Print, download, or save your certificate for your records.

If you lose your certificate, or need help, go to help.cmecertificateonline.com

 
Previous
Previous

2026 Cancer Updates GI & Breast, Nashville

Next
Next

2026 University of Kansas Cancer Center Breast Cancer Year in Review